Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China · Delayed Price · Currency is CNY 26.56
-0.24 (-0.90%)
Apr 9, 2026, 3:00 PM CST
SHA:600196 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3,371 | 2,770 | 2,386 | 3,731 | 4,729 |
Depreciation & Amortization | 3,461 | 3,002 | 2,965 | 2,336 | 1,804 |
Other Amortization | 263.12 | 169.44 | 153.49 | 111.69 | 144.79 |
Loss (Gain) From Sale of Assets | -69.35 | -371.01 | -5.56 | -125.6 | 15.42 |
Asset Writedown & Restructuring Costs | 30.85 | 63.64 | 64.34 | 200.48 | 321.01 |
Loss (Gain) From Sale of Investments | -3,306 | -2,035 | -2,988 | -1,832 | -4,491 |
Stock-Based Compensation | 207.24 | 21.07 | 35.9 | 54.48 | 64.29 |
Provision & Write-off of Bad Debts | 123.13 | 107.68 | 110.36 | 62.18 | 72.85 |
Other Operating Activities | 1,982 | 2,100 | 1,774 | 1,067 | 1,021 |
Change in Accounts Receivable | -1,011 | -397.52 | 1,605 | -2,077 | -1,795 |
Change in Inventory | 1,236 | 238.19 | -333.91 | -1,430 | -464.75 |
Change in Accounts Payable | -748.91 | -830.71 | -2,208 | 2,307 | 2,467 |
Operating Cash Flow | 5,213 | 4,477 | 3,414 | 4,218 | 3,938 |
Operating Cash Flow Growth | 16.45% | 31.13% | -19.05% | 7.10% | 52.64% |
Capital Expenditures | -4,448 | -4,410 | -5,337 | -5,889 | -4,973 |
Sale of Property, Plant & Equipment | 81.9 | 457.81 | 9.01 | 107.13 | 97.1 |
Cash Acquisitions | -33.98 | -215.79 | -924 | -1,197 | -1,307 |
Divestitures | 230.62 | 131.42 | 0.3 | 709.21 | 1,688 |
Investment in Securities | 1,479 | -668.06 | 1,568 | 1,225 | 214.13 |
Other Investing Activities | 545.32 | 1,091 | 863.84 | 980.64 | 422.65 |
Investing Cash Flow | -2,146 | -3,613 | -3,819 | -4,064 | -3,857 |
Long-Term Debt Issued | 36,258 | 30,931 | 23,514 | 30,649 | 29,529 |
Long-Term Debt Repaid | -36,982 | -30,948 | -22,041 | -26,280 | -27,392 |
Net Debt Issued (Repaid) | -724.03 | -16.46 | 1,472 | 4,369 | 2,137 |
Issuance of Common Stock | 607.5 | 40 | - | 4,509 | - |
Repurchase of Common Stock | -411.79 | -238.11 | - | - | - |
Common Dividends Paid | -2,231 | -2,395 | -2,455 | -2,374 | -1,914 |
Other Financing Activities | -485.06 | 1,607 | -353.55 | -2,076 | -1,043 |
Financing Cash Flow | -3,244 | -1,003 | -1,336 | 4,428 | -819.41 |
Foreign Exchange Rate Adjustments | -176.81 | 27.99 | 73.65 | 128.34 | -134.71 |
Net Cash Flow | -353.44 | -110.94 | -1,668 | 4,710 | -873.79 |
Free Cash Flow | 764.78 | 66.79 | -1,922 | -1,671 | -1,035 |
Free Cash Flow Growth | 1045.04% | - | - | - | - |
Free Cash Flow Margin | 1.84% | 0.16% | -4.64% | -3.80% | -2.65% |
Free Cash Flow Per Share | 0.29 | 0.03 | -0.72 | -0.64 | -0.40 |
Cash Income Tax Paid | 2,291 | 2,124 | 2,378 | 1,609 | 1,837 |
Levered Free Cash Flow | 837.93 | -274.97 | -4,046 | -1,692 | -1,087 |
Unlevered Free Cash Flow | 1,629 | 619.98 | -3,218 | -1,089 | -572.47 |
Change in Working Capital | -849.75 | -1,351 | -1,081 | -1,388 | 257.17 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.